Amerigen Pharmaceuticals Inc. FDA Record
- Latest inspection NAI · Jan 18, 2019
- No warning letters matched by name
Amerigen Pharmaceuticals Inc. has 4 FDA recalls, 2 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Amerigen Pharmaceuticals Inc." is on file.
- Latest recall
- D-0516-2019 · Class III · Feb 19, 2019
- Latest inspection
- Jan 18, 2019 · NAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 4 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 2 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Amerigen Pharmaceuticals Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 1 | 0 | 0 | 1 | 0 |
| 2018 | 0 | 0 | 0 | 3 | 0 |
| 2017 | 1 | 0 | 0 | 0 | 0 |
Reviewing Amerigen Pharmaceuticals Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Amerigen Pharmaceuticals Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0516-2019 | Class III | Temozolomide Capsules, 5 mg, packaged in a) 5-count bottle (NDC 43975-252-05) b) 14-count bottle… | Feb 19, 2019 |
| D-0345-2019 | Class III | Temozolomide Capsules, 180 mg, packaged in a 14 count bottles, Rx only, Mfd, by: Stason… | Dec 20, 2018 |
| D-0344-2019 | Class III | Temozolomide Capsules, 20 mg, packaged in a a) 5-count (NDC 43975-253-05) and b) 14 count (NDC… | Dec 20, 2018 |
| D-0249-2019 | Class III | Temozolomide capsules, 20 mg, packaged in a) 5-count bottle(NCD 43975-253-05), b) 14-count bottle… | Oct 5, 2018 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Jan 18, 2019 | Lyndhurst, NJ | Drugs | No Action Indicated (NAI) | 3008849302 |
| Jul 27, 2017 | Lyndhurst, NJ | Drugs | Voluntary Action Indicated (VAI) | 3008849302 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3008849302 | Lyndhurst, NJ | 2 | Jan 18, 2019 |
Amerigen Pharmaceuticals Inc. and the FDA: common questions
Has Amerigen Pharmaceuticals Inc. received an FDA warning letter?
No FDA warning letter addressed to the name "Amerigen Pharmaceuticals Inc." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Amerigen Pharmaceuticals Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Amerigen Pharmaceuticals Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Amerigen Pharmaceuticals Inc.?
The most recent FDA inspection on file ended Jan 18, 2019 at Lyndhurst, NJ and was classified NAI. FDA has 2 inspections of Amerigen Pharmaceuticals Inc. on file.
Has Amerigen Pharmaceuticals Inc. had an FDA recall?
Yes. Amerigen Pharmaceuticals Inc. has 4 FDA recalls on record. The most recent started Feb 19, 2019.
Need more than this page shows? Ask about Amerigen Pharmaceuticals Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.